1. To model or not to model: lessons from two vaccinations

   • Livio Garattini
   • Anna Padula

   Editorial 26 January 2011 Pages: 189 - 191

2. Analysis of physicians’ perspectives versus patients’ preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma

   • Axel C. Mühlbacher
   • Matthias Nübling

   Original Paper 28 January 2010 Pages: 193 - 203

   

3. Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy

   • Eberhard Wille
   • Jürgen Scholze
   • Kerstin Uhl-Hochgraeber

   Original Paper 20 April 2010 Pages: 205 - 218

   

4. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes

   • Kristina S. Boye
   • Louis S. Matza
   • Aodan Tynan

   Original Paper 12 March 2010 Pages: 219 - 230

5. Practical issues in handling data input and uncertainty in a budget impact analysis

   • M. J. C. Nuijten
   • T. Mittendorf
   • U. Persson

   Original Paper Open access 03 April 2010 Pages: 231 - 241

6. Deriving reference values and utilities for the QoL-AGHDA in adult GHD

   • J. J. V. Busschbach
   • B. H. R. Wolffenbuttel
   • M. Kołtowska-Häggström

   Original Paper Open access 17 April 2010 Pages: 243 - 252

   

7. Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece

   • Nikos Maniadakis
   • Mattias Ekman
   • John Yfantopoulos

   Original Paper 22 April 2010 Pages: 253 - 261

   

8. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment

   • Michael Drummond
   • Bengt Jönsson
   • Tom Stargardt

   Original Paper Open access 28 August 2010 Pages: 263 - 271

9. Health care costs and their predictors of inflammatory bowel diseases in Germany

   • Anne Prenzler
   • Bernd Bokemeyer
   • Thomas Mittendorf

   Original Paper 22 October 2010 Pages: 273 - 283